Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 60.63%709.65M | 60.64%592.65M | 115.23%593.96M | 15.46%469.87M | 11.67%441.8M | -9.81%368.93M | -29.81%275.96M | 0.84%406.96M | 62.16%395.64M | 87.35%409.06M |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | --80M | --115.1M | --0 | ---- | ---- |
| Notes receivable and accounts receivable | 12.22%273.38M | 15.12%249.18M | 18.59%259.36M | 10.13%227.05M | 11.34%243.6M | 35.54%216.46M | 41.17%218.7M | 58.78%206.17M | 41.02%218.79M | 5.98%159.7M |
| -Notes receivable | 148.30%44.71M | 90.14%34.71M | 79.81%30.48M | -2.21%23.88M | -32.66%18.01M | --18.26M | --16.95M | --24.42M | --26.74M | ---- |
| -Accounts receivable | 1.36%228.67M | 8.20%214.47M | 13.45%228.88M | 11.79%203.18M | 17.47%225.6M | 24.11%198.2M | 30.23%201.75M | 39.97%181.76M | 23.79%192.05M | 5.98%159.7M |
| Other receivables (including interest and dividends) | 1.50%382.78K | -33.26%429.17K | -22.46%568.58K | -9.76%705.4K | -48.85%377.13K | -49.92%643.05K | -54.53%733.27K | -61.45%781.66K | -66.23%737.35K | -58.47%1.28M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| -Other receivable | 1.50%382.78K | ---- | -22.46%568.58K | ---- | -48.85%377.13K | ---- | -54.53%733.27K | ---- | -66.23%737.35K | ---- |
| Contractual assets | --404.89K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Advance payment | -58.28%5.54M | -56.92%4.6M | -27.93%5.56M | 137.67%9.89M | 182.45%13.28M | 46.10%10.69M | 34.18%7.72M | -46.10%4.16M | -21.46%4.7M | -49.68%7.32M |
| Inventories | 0.58%150.46M | 13.59%170.89M | 20.17%158.95M | 29.65%170.8M | 17.47%149.59M | 23.96%150.44M | 11.13%132.27M | 15.00%131.74M | 12.54%127.34M | -1.87%121.36M |
| Receivable financing | 13.42%33.04M | 49.13%32.96M | 4.62%28.14M | 47.23%34.18M | 71.10%29.13M | -27.79%22.1M | -30.15%26.9M | -42.05%23.21M | -44.85%17.03M | 41.69%30.6M |
| Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other current assets | 126.41%14.29M | 6.27%8.16M | 27.68%8.25M | 50.28%7.81M | 36.51%6.31M | 71.46%7.68M | 155.45%6.47M | 162.49%5.2M | 202.75%4.62M | 183.76%4.48M |
| Total current assets | 34.28%1.19B | 23.56%1.06B | 34.57%1.05B | 18.26%920.31M | 14.99%884.1M | 16.78%856.93M | 9.55%783.85M | 11.21%778.23M | 25.06%768.86M | 22.40%733.8M |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other equity investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-current financial assets | 86.16%481.69M | 46.99%454.73M | 16.06%337.14M | -0.65%312.68M | -26.41%258.76M | -10.07%309.36M | -18.66%290.49M | -17.12%314.72M | -31.38%351.62M | -38.60%344.01M |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Long-term equity investment | -1.75%1.7M | -2.42%1.71M | -1.99%1.71M | -1.91%1.72M | -1.82%1.73M | -1.04%1.75M | -1.55%1.75M | -1.64%1.75M | -1.68%1.76M | 1.13%1.77M |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Fixed assets | -6.94%195.03M | ---- | -3.90%203.93M | ---- | 2.74%209.57M | ---- | 15.59%212.2M | ---- | 4.20%203.98M | ---- |
| Constru in process | -18.23%20.53M | ---- | 65.07%31.68M | ---- | 6.88%25.11M | ---- | -8.83%19.19M | ---- | 203.11%23.49M | ---- |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Intangible assets | -26.09%24.9M | -28.68%26.46M | -28.89%28.29M | -27.27%30.9M | -25.85%33.69M | -13.01%37.1M | -10.69%39.78M | 8.57%42.49M | 11.19%45.43M | 2.13%42.66M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Goodwill | -88.13%506.34K | -24.87%4.27M | -24.87%4.27M | -24.87%4.27M | -24.87%4.27M | -39.12%5.68M | -39.12%5.68M | -39.12%5.68M | -39.12%5.68M | 0.00%9.33M |
| Long deferred expense | -34.17%929.06K | -31.48%1.05M | -29.18%1.17M | -19.09%1.29M | 1.04%1.41M | 2.56%1.53M | 3.90%1.65M | -7.37%1.6M | -24.77%1.4M | -33.75%1.49M |
| Deferred tax assets | -91.90%1.06M | 22.91%19.15M | 26.05%16.92M | 14.01%14.4M | 8.87%13.13M | 16.00%15.58M | 5.47%13.43M | 14.69%12.63M | 26.65%12.06M | --13.43M |
| Usufruct assets | 138.90%636.89K | 78.21%732.43K | -85.71%66.65K | -78.43%122.19K | -60.00%266.6K | --411K | -91.57%466.54K | -90.53%566.52K | -89.64%666.49K | ---- |
| Other non current assets | 105.61%5.28M | -0.60%3.58M | -34.13%2.55M | -47.31%2.28M | -66.20%2.57M | -73.86%3.6M | -81.21%3.88M | -70.95%4.32M | -52.13%7.6M | 122.03%13.76M |
| Total non current assets | 33.02%732.27M | 23.11%746.13M | 6.66%627.74M | -1.59%601.16M | -15.79%550.5M | -5.60%606.07M | -10.54%588.52M | -9.32%610.9M | -18.45%653.69M | -22.93%642.03M |
| Total assets | 33.79%1.92B | 23.38%1.8B | 22.60%1.68B | 9.53%1.52B | 0.85%1.43B | 6.34%1.46B | -0.07%1.37B | 1.14%1.39B | 0.44%1.42B | -3.96%1.38B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -23.33%23.02M | 22.22%33.03M | 65.08%33.05M | 98.48%28.02M | 281.71%30.03M | 172.72%27.02M | 102.02%20.02M | 42.45%14.12M | 773.93%7.87M | --9.91M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Notes payable and accounts payable | 2.56%168.46M | 15.36%171.74M | 38.59%167.96M | 52.44%157.31M | 45.88%164.25M | 54.85%148.88M | 15.75%121.19M | 13.62%103.2M | 13.13%112.6M | 15.68%96.14M |
| -Notes payable | --925.48K | --2M | --4M | --2M | ---- | ---- | --0 | --0 | -88.97%854.04K | -13.16%5.61M |
| -Accounts payable | 1.99%167.53M | 14.01%169.74M | 35.29%163.96M | 50.50%155.31M | 46.99%164.25M | 64.44%148.88M | 34.15%121.19M | 37.95%103.2M | 21.74%111.75M | 18.11%90.54M |
| Contract liabilities | -73.68%4.12M | -25.91%5.68M | 40.33%4.42M | 389.20%16.76M | 541.11%15.64M | 487.21%7.66M | -65.19%3.15M | 143.95%3.43M | 1.48%2.44M | -72.32%1.3M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Salaries payable | -4.87%23.35M | 0.18%17.25M | -6.28%14.73M | 7.12%14.66M | 17.05%24.55M | 9.33%17.21M | 14.82%15.72M | 8.89%13.69M | 20.71%20.97M | 14.90%15.74M |
| Taxs payable | -52.55%3.77M | 2.73%7.27M | 271.34%24.44M | -52.33%7.77M | -50.07%7.94M | -65.65%7.08M | -61.32%6.58M | 21.86%16.29M | 328.94%15.9M | 365.01%20.6M |
| Other payable (including interest and dividends) | 130.87%24.21M | 770.32%26.81M | 1,492.04%53.35M | 400.46%17.43M | 213.66%10.49M | -36.33%3.08M | -5.39%3.35M | 25.73%3.48M | 176.87%3.34M | 229.06%4.84M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| -Dividend payable | ---- | ---- | --34.8M | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Other payable | 130.87%24.21M | ---- | 453.53%18.55M | ---- | 213.66%10.49M | ---- | -5.39%3.35M | ---- | 176.87%3.34M | ---- |
| Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non current liabilities due within one year | 36.23%391.22K | -1.52%388.3K | -82.61%73.89K | -56.63%181.58K | -30.60%287.18K | --394.28K | -77.62%424.83K | -77.69%418.7K | -77.70%413.82K | ---- |
| Other current liabilities | 76.83%23.17M | 56.88%21.08M | 31.98%15.94M | -19.05%13.23M | -23.14%13.1M | 39,653.79%13.43M | 32,239.58%12.08M | 31,845.82%16.35M | 16,970.97%17.05M | -94.48%33.79K |
| Total current liabilities | 1.58%270.48M | 26.02%283.24M | 72.02%313.96M | 49.36%255.36M | 47.46%266.28M | 51.28%224.76M | 14.19%182.51M | 28.77%170.97M | 42.10%180.58M | 35.16%148.58M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Estimate liabilities | --24.58M | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Deferred tax liabilities | 262.63%44.73M | 115.60%44.32M | 50.14%26.61M | -2.26%21.33M | -57.60%12.33M | -29.47%20.55M | -43.65%17.72M | -37.51%21.83M | -45.18%29.09M | -46.67%29.14M |
| Long term deferred income | -30.68%4.42M | -23.03%4.73M | -21.81%5.08M | -17.29%5.67M | -11.59%6.38M | -11.22%6.15M | -10.43%6.5M | -9.71%6.86M | -9.06%7.21M | 14.20%6.92M |
| Lease liabilities | --267.03K | --366.77K | ---- | ---- | ---- | ---- | -98.39%73.89K | -96.43%181.58K | -94.84%287.18K | ---- |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Total non current liabilities | 295.51%74M | 85.06%49.41M | 30.43%31.7M | -6.45%27.01M | -48.87%18.71M | -25.97%26.7M | -43.90%24.3M | -39.37%28.87M | -45.03%36.59M | -46.53%36.07M |
| Total liabilities | 20.87%344.48M | 32.29%332.65M | 67.13%345.65M | 41.30%282.36M | 31.23%284.99M | 36.19%251.46M | 1.80%206.81M | 10.78%199.83M | 12.15%217.17M | 4.10%184.64M |
| Shareholders equity | ||||||||||
| Paid-in capital | 1.55%353.41M | 0.00%348M | 0.00%348M | 0.00%348M | 0.00%348M | 0.00%348M | 0.00%348M | 0.00%348M | 0.00%348M | 0.00%348M |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Capital reserve funds | 217.03%179.18M | 0.00%56.52M | 0.00%56.52M | 0.00%56.52M | 0.00%56.52M | 0.00%56.52M | 0.00%56.52M | 0.00%56.52M | 0.00%56.52M | 0.00%56.52M |
| Surplus reserve funds | 28.30%176.7M | 3.61%137.73M | 3.61%137.73M | 3.61%137.73M | 3.61%137.73M | 3.49%132.93M | 3.49%132.93M | 3.49%132.93M | 3.49%132.93M | 5.19%128.45M |
| Retained profit | 46.03%862.35M | 41.42%922.27M | 29.78%785.19M | 8.96%682.03M | -7.81%590.52M | 4.50%652.14M | -0.06%605.03M | 0.08%625.96M | -1.84%640.53M | -9.32%624.04M |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other composite income | -1,470.29%-481.8K | -96.60%-434.65K | -239.70%-839.17K | 109.18%22.76K | 110.70%35.16K | 7.55%-221.08K | 18.47%-247.04K | -113.71%-248K | -224.05%-328.61K | -190.13%-239.14K |
| Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Shareholders equity without minority interests | 38.70%1.57B | 23.10%1.46B | 16.14%1.33B | 5.26%1.22B | -3.81%1.13B | 2.82%1.19B | 0.37%1.14B | 0.42%1.16B | -0.65%1.18B | -4.77%1.16B |
| Minority interests | -77.52%3.78M | -62.78%8.26M | -55.92%10.28M | -43.36%14.81M | -39.43%16.8M | -35.58%22.18M | -27.59%23.32M | -24.84%26.14M | -25.71%27.74M | -14.84%34.43M |
| Total shareholder equity | 37.00%1.57B | 21.53%1.47B | 14.70%1.34B | 4.19%1.24B | -4.63%1.15B | 1.71%1.21B | -0.40%1.17B | -0.32%1.19B | -1.42%1.21B | -5.10%1.19B |
| Total liabilityies and equity | 33.79%1.92B | 23.38%1.8B | 22.60%1.68B | 9.53%1.52B | 0.85%1.43B | 6.34%1.46B | -0.07%1.37B | 1.14%1.39B | 0.44%1.42B | -3.96%1.38B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.